Evidence map›Paper›PMID 37143014›Full record

SynthesisBMC psychiatry2023

Acupuncture for post-stroke depression: a systematic review and network meta-analysis.

Wai Lam Ching, Hui Juan Li, Jianwen Guo, Liang Yao, Janita Chau, Suzanne Lo, Chun Sum Yuen, Bacon Fung Leung Ng, Edwin Chau-Leung Yu, Zhaoxiang Bian and 2 more

Open access · goldAbstract readSystematic ReviewNetwork Meta-Analysis
In one paragraph

Synthesis in BMC psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 4 pooled it
37.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 4 syntheses or guidelines pooled it, 94 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. E2F2 inhibits hippocampal neurogenesis in poststroke depression rats via the miR-1290/CBR1 axis.Mammalian genome : official journal of the International Mammalian Genome Society · 2025
    Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 4 countries.

Wai Lam ChingBiomedical Sciences and Chinese Medicine, School of Biological Sciences, Nanyang Technological University, Singapore, 637551, Singapore.
Hui Juan LiHong Kong Chinese Medicine Clinical Study Centre, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, Hong Kong SAR, China.
Jianwen GuoBrain Center, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangdong University of Chinese Medicine, Guangzhou, China.
Liang YaoDepartment of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.
Janita ChauThe Nethersole School of Nursing, Faculty of Medicine, the Chinese University of Hong Kong, Ma Liu Shui, Hong Kong SAR, China.
Suzanne LoThe Nethersole School of Nursing, Faculty of Medicine, the Chinese University of Hong Kong, Ma Liu Shui, Hong Kong SAR, China.
Chun Sum YuenSchool of Chinese medicine, Hong Kong Baptist University, Kowloon, Hong Kong SAR, China.
Bacon Fung Leung NgDepartment of Rehabilitation Sciences, Hong Kong Polytechnic University, Kowloon, Hong Kong SAR, China.
Edwin Chau-Leung YuHong Kong Association for Integration of Chinese-Western Medicine Limited, Kowloon, Hong Kong SAR, China.
Zhaoxiang BianHong Kong Chinese Medicine Clinical Study Centre, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, Hong Kong SAR, China.
Alexander Y LauDepartment of Medicine and Therapeutics and Hong Kong Institute of Integrative Medicine, Prince of Wales Hospital, Faculty of Medicine, the Chinese University of Hong Kong, Kowloon, Hong Kong SAR, China. alexlau@cuhk.edu.hk.
Linda Ld ZhongBiomedical Sciences and Chinese Medicine, School of Biological Sciences, Nanyang Technological University, Singapore, 637551, Singapore. linda.zhong@ntu.edu.sg.
Hong Kong Baptist University · HKChinese University of Hong Kong · HKGuangdong Provincial Hospital of Traditional Chinese Medicine · CNHong Kong Association For Integration Of Chinese-Western Medicine · CNHong Kong Polytechnic University · HKImpact · CANanyang Technological University · SGPrince of Wales Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients with post-stroke depression (PSD) usually experience anxiety, hopelessness, and insomnia, which have a negative impact on their daily activities and post-stroke rehabilitation. Acupuncture (AC), as a minimally invasive technique, has become a popular choice for improving depression symptoms. However, it is still unclear which therapy is associated with the best outcomes for PSD. In this review, we aimed to explore the impact of AC in alleviating symptoms of PSD and to evaluate the difference in effectiveness between AC combined with pharmacotherapies and various non-pharmacotherapies.

methodsSix databases and three clinical trials registration platforms were searched from inception to March 2023. Randomized clinical trial comparing needle-based AC with pharmacotherapy, and other non-pharmacotherapy or invalid group were included. Two independent reviewers identified eligible studies, and collected data using a pre-made form. A Bayesian network meta-analysis was conducted to assess and compare different techniques using RStudio 3.6.0 with the package 'GEMTC' V.0.8.1. The primary outcome was the efficacy for PSD assessed by scales measuring depressive symptoms. The secondary outcomes were effectiveness for neurological function and the quality of life. The ranking probabilities for all treatment interventions was performed using the Surface Under the Cumulative Ranking curve (SUCRA). The risk of bias was assessed by using the Revised Cochrane Risk of Bias tool 2.

resultsSixty-two studies, involving 5308 participants published from 2003 to 2022, were included. The results showed that compared with western medicine (WM) (defined as pharmacotherapy for PSD), AC alone or with repetitive transcranial magnetic stimulation (RTMS), Traditional Chinese medicine (TCM) alone or with WM, were superior for alleviating depression symptoms. Compared to Usual Care, AC alone or plus other therapies could significantly decrease scores on the Hamilton Depression Rating scale. According to result of SUCRA, AC plus RTMS had the highest probability of improving depressive symptoms with a probability of 49.43%.

conclusionsThe results of this study indicate that AC alone or combined with other therapies appears to be effective in improving depression symptoms of stroke survivors. Moreover, in comparison to WM, AC alone or plus RTMS, TCM, TCM with WM, or WM, were more effective in improving depression symptoms of PSD. Also, AC with RTMS seems to be the most effective with the highest probability. REGISTRATION: This study was registered in the International Prospective Register of Systematic Reviews (PROSPERO) database in November 2020 and updated in July 2021. The registration number is CRD42020218752.

Indexed as

Acupuncture TherapyStrokeBayes TheoremDepressionHumansQuality of LifeRandomized Controlled Trials as TopicAcupunctureNetwork meta-analysisPost-stroke depression

Identifiers

PMID37143014
PMCPMC10161596
OpenAlexW4368364151

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.